Table 3.
The secondary outcomes of our study.
| VARIABLE | GROUP | TIME |
||
|---|---|---|---|---|
| BASE | 3RD MONTH | 9TH MONTH | ||
| LBP VASc | CGa | 254, 3.81 (0.12) | 158, 2.58 (0.13) | 307, 2.57 (0.10) |
| IGa | 427, 4.04 (0.10) | 188, 2.69 (0.12) | 256, 2.67 (0.10) | |
| Intervention effectb | – | 0.88 (0.55–1.41) | 0.88 (0.59–1.33) | |
| COMIc | CGa | 254, 3.40 (0.10) | 158, 3.46 (0.12) | 307, 2.88 (0.07) |
| IGa | 427, 3.60 (0.08) | 188, 3.53 (0.11) | 256, 2.86 (0.09) | |
| Intervention effectb | – | 0.88 (0.58–1.31) | 0.81 (0.60–1.10) | |
a
Data are presented as: n, mean (SD).
b
Data are presented as: OR 95% CI (odds ratio, 95% confidence interval).
c
GEE model adjusted by baseline variables was used. Reference categories were time at baseline and control group.